Jingwen Niu1, Lei Zhang1, Jing Fan1, Jingwen Liu1, Qingyun Ding1, Yuzhou Guan1, Shuang Wu1, Liying Cui1, Mingsheng Liu2. 1. Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China. 2. Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China. liumingsheng_pumch@163.com.
Abstract
BACKGROUNDS: Nerve ultrasound has been proven to be an accurate tool in diagnosing chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). However, its value in guiding treatment has not been well evaluated. The aim of this study was to explore whether nerve ultrasound and its changing trend could predict the response to immune treatment in CIDP. METHODS: Eighty-nine therapy-naive CIDP patients were recruited prospectively and treated with steroids and/or intravenous immunoglobulin (IVIG). Ultrasonographic and electrophysiological studies were performed on the median and ulnar nerves before treatment in all patients and followed up in 45 patients. The cross-sectional area (CSA) was measured at ten sites on both the median and ulnar nerves. RESULTS: The response rate to steroids (95%) was significantly higher than that to IVIG (70%) (P = 0.001) in patients with normal or moderately enlarged CSA, while there was no significant difference in the response rate between steroid therapy (84%) and IVIG (75%) (P = 0.653) in patients with markedly enlarged CSA. CSAs decreased in 15 patients during follow-up, most of whom had good IVIG and steroid responses (83%) and no need for immune suppressant treatment (82%). CONCLUSIONS: Nerve ultrasonography could help guide treatment strategies in patients with CIDP. Patients with normal or moderately enlarged CSA may respond better to steroids than to IVIG. The decrease in CSA after treatment may also indicate better prognosis.
BACKGROUNDS: Nerve ultrasound has been proven to be an accurate tool in diagnosing chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). However, its value in guiding treatment has not been well evaluated. The aim of this study was to explore whether nerve ultrasound and its changing trend could predict the response to immune treatment in CIDP. METHODS: Eighty-nine therapy-naive CIDP patients were recruited prospectively and treated with steroids and/or intravenous immunoglobulin (IVIG). Ultrasonographic and electrophysiological studies were performed on the median and ulnar nerves before treatment in all patients and followed up in 45 patients. The cross-sectional area (CSA) was measured at ten sites on both the median and ulnar nerves. RESULTS: The response rate to steroids (95%) was significantly higher than that to IVIG (70%) (P = 0.001) in patients with normal or moderately enlarged CSA, while there was no significant difference in the response rate between steroid therapy (84%) and IVIG (75%) (P = 0.653) in patients with markedly enlarged CSA. CSAs decreased in 15 patients during follow-up, most of whom had good IVIG and steroid responses (83%) and no need for immune suppressant treatment (82%). CONCLUSIONS: Nerve ultrasonography could help guide treatment strategies in patients with CIDP. Patients with normal or moderately enlarged CSA may respond better to steroids than to IVIG. The decrease in CSA after treatment may also indicate better prognosis.
Authors: P Y K Van den Bergh; R D M Hadden; P Bouche; D R Cornblath; A Hahn; I Illa; C L Koski; J-M Léger; E Nobile-Orazio; J Pollard; C Sommer; P A van Doorn; I N van Schaik Journal: Eur J Neurol Date: 2010-03 Impact factor: 6.089
Authors: G Fargeot; K Viala; M Theaudin; M-A Labeyrie; R Costa; J M Léger; D Adams; C Vandendries; C Labeyrie Journal: Eur J Neurol Date: 2018-12-10 Impact factor: 6.089
Authors: Carina Bunschoten; Bart C Jacobs; Peter Y K Van den Bergh; David R Cornblath; Pieter A van Doorn Journal: Lancet Neurol Date: 2019-05-07 Impact factor: 44.182
Authors: Ingrid J T Herraets; H Stephan Goedee; Johan A Telleman; Ruben P A van Eijk; J Thies van Asseldonk; Leo H Visser; Leonard H van den Berg; W Ludo van der Pol Journal: Neurology Date: 2020-01-20 Impact factor: 9.910
Authors: Jos Oudeman; Filip Eftimov; Gustav J Strijkers; Joppe J Schneiders; Stefan D Roosendaal; Maurits P Engbersen; Martijn Froeling; H Stephan Goedee; Pieter A van Doorn; Matthan W A Caan; Ivo N van Schaik; Mario Maas; Aart J Nederveen; Marianne de Visser; Camiel Verhamme Journal: Neurology Date: 2019-12-11 Impact factor: 9.910
Authors: Emily K Mathey; Susanna B Park; Richard A C Hughes; John D Pollard; Patricia J Armati; Michael H Barnett; Bruce V Taylor; P James B Dyck; Matthew C Kiernan; Cindy S-Y Lin Journal: J Neurol Neurosurg Psychiatry Date: 2015-02-12 Impact factor: 10.154
Authors: Marieke H J van Rosmalen; H Stephan Goedee; Anouk van der Gijp; Theo D Witkamp; Ruben P A van Eijk; Fay-Lynn Asselman; Leonard H van den Berg; Stefano Mandija; Martijn Froeling; Jeroen Hendrikse; W Ludo van der Pol Journal: J Neurol Date: 2020-09-23 Impact factor: 4.849